Vitiligo as a post-bone marrow transplantation complication

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 7, 2007, Pages 485-487

  Cathcart, Shelley ^a   Morrell, Dean ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CB #7287 ^*  (United States)

Author keywords

Autoimmune; Fanconi anemia; Graft versus host disease

Indexed keywords

ANDROGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; OXYMETHOLONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRIAMCINOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; CASE REPORT; DRUG COST; DRUG WITHDRAWAL; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MALE; MUCOSA INFLAMMATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SIBLING; T CELL DEPLETION; TRANSFUSION; VEIN OCCLUSION; VITILIGO; WHOLE BODY RADIATION;

AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CHILD; GRAFT VS HOST DISEASE; HUMANS; MALE; VITILIGO;

EID: 34347382383     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31806210ef     Document Type: Review

References (18)

1. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest. 2000;80:1299.
2. Rouquette-Gally AM, Boyeldieu D, Prost AC, et al. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term surviving patients. Transplantation. 1988;46:238-240.
3. Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplantation. 1998;22:873-881.
4. Drobyski WR, Potluri J, Sauer D, et al. Autoimmune haemolytic anaemia following T cell depleted allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;17:1093-1099.
5. Chen FE, Owen I, Savage D, et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant. 1997;19:491-495.
6. Al-Fiar FZ, Colwill R, Lipton JH, et al. Abnormal thyroid stimulating hormone levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant. 1997;19:1019-1022.
7. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16:208.
8. Neumeister P, Strunk D, Apfelbeck U, et al. Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Lancet. 2000;355:1334-1335.
9. Alajlan A, Alfadley A, Pedersen KT. Transfer of vitiligo after allogeneic bone marrow transplantation. J Am Acad Dermatol. 2002;46:606-610.
10. Bellou A, Kanny G, Fremont S, et al. Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol. 1997;78:513-516.
11. Saarinen UM. Transfer of latent atopy by bone marrow transplantation? A case report. J Allergy Clin Immunol. 1984;74:196-200.
12. Wyatt DT, Lum LG, Casper J, et al. Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant. 1990;5:357-361.
13. Ritchie DS, Sainani A, D'Souza A, et al. Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation. Am J Hematol. 2005;79:299-302.
14. Olaguibel J, Almodovar A, Giner A, et al. Passive transfer of contact sensitivity to colophony as a complication of an allogenic bone-marrow transplant. Contact Dermatitis. 1989;20:182-184.
15. Aubin F, Cahn JY, Ferrand C, et al. Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Lancet. 2000;355:626-627.
16. Au WY, Yeung CK, Chan HH, et al. Generalized vitiligo after lymphocyte infusion for relapsed leukaemia. Br J Dermatol. 2001;145:1015-1017.
17. Cho SB, Roh MR, Chung KY, et al. Generalized vitiligo after allogeneic bone marrow transplantation. Acta Derm Venereol. 2005;85:82-83.
18. Carlens S, Ringden O, Remberger M, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22:755.